DOSE-RELATED KINETICS OF ASPIRIN - PRESYSTEMIC ACETYLATION OF PLATELET CYCLOOXYGENASE

被引：498

作者：

PEDERSEN, AK ^{[1
]}

FITZGERALD, GA ^{[1
]}

机构：

[1] VANDERBILT UNIV, DIV CLIN PHARMACOL, NASHVILLE, TN 37232 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1984年 / 311卷 / 19期

关键词：

D O I：

10.1056/NEJM198411083111902

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1206 / 1211

页数：6

共 34 条

[21] SELECTIVE CUMULATIVE INHIBITION OF PLATELET THROMBOXANE PRODUCTION BY LOW-DOSE ASPIRIN IN HEALTHY-SUBJECTS [J].

PATRIGNANI, P ;

FILABOZZI, P ;

PATRONO, C .

JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (06) :1366-1372

[22] LOW-DOSE ASPIRIN AND INHIBITION OF THROMBOXANE B-2 PRODUCTION IN HEALTHY-SUBJECTS [J].

PATRONO, C ;

CIABATTONI, G ;

PINCA, E ;

PUGLIESE, F ;

CASTRUCCI, G ;

DESALVO, A ;

SATTA, MA ;

PESKAR, BA .

THROMBOSIS RESEARCH, 1980, 17 (3-4) :317-327

[23]

PEDERSEN AK, J PHARM SCI

[24] INHIBITION OF PROSTACYCLIN AND PLATELET THROMBOXANE A2 AFTER LOW-DOSE ASPIRIN [J].

PRESTON, FE ;

WHIPPS, S ;

JACKSON, CA ;

FRENCH, AJ ;

WYLD, PJ ;

STODDARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02) :76-79

[25] PLASMA ASPIRIN ESTERASES IN NORMAL INDIVIDUALS, PATIENTS WITH ALCOHOLIC LIVER-DISEASE AND RHEUMATOID-ARTHRITIS - CHARACTERIZATION AND THE IMPORTANCE OF THE ENZYMIC COMPONENTS [J].

RAINSFORD, KD ;

FORD, NLV ;

BROOKS, PM ;

WATSON, HM .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (05) :413-420

[26]

REILLY IAG, 1984, CLIN RES, V32, pA320

[27] MECHANISM OF EFFECT OF ASPIRIN ON HUMAN PLATELETS .1. ACETYLATION OF A PARTICULATE FRACTION PROTEIN [J].

ROTH, GJ ;

MAJERUS, PW .

JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (03) :624-632

[28] ABSORPTION KINETICS OF ASPIRIN IN MAN FOLLOWING ORAL ADMINISTRATION OF AN AQUEOUS-SOLUTION [J].

ROWLAND, M ;

SHOLKOFF, SD ;

HARRIS, PA ;

RIEGELMAN, S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (03) :379-+

[29] METABOLISM OF SALICYLATE DURING CHRONIC ASPIRIN THERAPY [J].

RUMBLE, RH ;

BROOKS, PM ;

ROBERTS, MS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) :41-45

[30]

SHAND DG, 1971, CLIN PHARMACOL THER, V12, P769

← 1 2 3 4 →